Innovative drug out-licensing deal value (half year)
China · as of 30 Jun 2026
Innovative drug out-licensing deal value in China (half year) stood at 100 billion USD as of 30 June 2026 (State Council).
- Publisher
- State Council
- Authority tier
- T1 Official
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
The total value of China's innovative drug out-licensing deals exceeded 100 billion U.S. dollars in the first half of the year, reaching a record high, the Ministry of Industry and Information Technology (MIIT) said Monday.
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Other sources disagree
1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.
| Value | Divergence | Source organisation | Document | Locator | Details |
|---|---|---|---|---|---|
| 110 billion USD | +10.0% | NHSA | 国家医疗保障局 医保动态 我国上半年创新药对外授权交易额超千亿美元 | 我国上半年创新药对外授权约1100亿美元 创历史新高 | Open record |
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_M4C4PFSZGMYXXQMTX08MF8QXZ5
- MLA
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026, https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_M4C4PFSZGMYXXQMTX08MF8QXZ5.
- Chicago
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026. https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_M4C4PFSZGMYXXQMTX08MF8QXZ5.
- BibTeX
- @misc{statecouncil2026innovativef8qxz5, author = {{State Council of China}}, title = {Value of China's innovative drug out-licensing deals hit new high in H1}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_M4C4PFSZGMYXXQMTX08MF8QXZ5}, note = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary Source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Value of China's innovative drug out-licensing deals hit new high in H1
- Type
- Press release
- Published
- —
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_M4C4PFSZGMYXXQMTX08MF8QXZ5